Skip to main content
. 2014 Apr 1;9(1):156. doi: 10.1186/1556-276X-9-156

Table 2.

Tissue to plasma exposure ratio of paclitaxel for tumor, liver, and spleen following intravenous administration

Tissue to plasma ratio
Formulation
  Cremophor EL:ethanol Nanosuspension
Tumor AUC0-8/plasma AUC0-8
0.7
8.3
Liver AUC0-8/plasma AUC0-8
3.6
810.0
Spleen AUC0-8/plasma AUC0-8 1.1 16.8

AUC0-8, area under the concentration-time profile from 0 to 8 h.